A phase I study of FB001 for the treatment of autoimmune diseases

Trial Profile

A phase I study of FB001 for the treatment of autoimmune diseases

Planning
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2014

At a glance

  • Drugs FB 001 (Primary)
  • Indications Autoimmune disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top